Patients do not understand basic information about cholesterol and other lipid risk factors, according to two new surveys sponsored by Miami-based Kos Pharmaceuticals and conducted by Yankelovich Partners Inc.
Patients do not understand basic information about cholesterol and other lipid risk factors, according to two new surveys sponsored by Miami-based Kos Pharmaceuticals and conducted by Yankelovich Partners Inc.
Experts presented the results at a Dyslipidemia Roundtable sponsored by the Citizens for Public Action on Blood Pressure and Cholesterol Inc. in New York in September.
Understanding and maintaining healthy levels of cholesterol and other lipids, such as low-density lipoproteins, high-density lipoproteins and triglycerides, is critical to reducing a patient's risk of coronary heart disease.
But nearly half of surveyed patients with high cholesterol said that their physicians had never discussed with them all of the lipids that factor into total lipid management. And more than half could not identify which lipoprotein was good and which was bad.
Physicians, meanwhile, appear to be in the dark about their patients' lack of knowledge. More than half of surveyed physicians said that their patients are informed about the components that comprise the total lipid profile.
Although a majority of physicians said they spend at least some time discussing good lipoprotein (HDL) and triglyceride levels with their patients, only 6% of high-cholesterol patients said their doctors had discussed achieving ideal targets for HDL levels. Only 5% had been told what their ideal triglyceride levels were.
"As we continue to learn more about HDL, triglycerides and Lp(a) [an emerging risk factor], it is abundantly clear that measurement of total cholesterol is no longer enough to determine heart disease risk," said Antonio Gotti, M.D., Ph.D., a dean and a professor at Cornell University. "Awareness of low-density lipoprotein, high-density lipoprotein and triglyceride levels is critical in assessing appropriate therapeutic options. What works for one individual will not necessarily work for another." PR
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.